Eventide Asset Management - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$22,021,470
-20.5%
438,5000.0%0.40%
-15.4%
Q2 2023$27,713,200
+40.5%
438,5000.0%0.47%
+29.3%
Q1 2023$19,728,115
+2.7%
438,5000.0%0.36%
-4.5%
Q4 2022$19,210,685
-33.5%
438,5000.0%0.38%
-33.3%
Q3 2022$28,893,000
+30.4%
438,5000.0%0.57%
+19.8%
Q2 2022$22,149,000
-41.5%
438,500
-26.0%
0.47%
-20.1%
Q1 2022$37,849,000
-10.7%
592,500
+49.7%
0.59%
+9.4%
Q4 2021$42,394,000
+15.8%
395,800
+11.2%
0.54%
+12.2%
Q3 2021$36,600,000
-9.9%
356,000
-22.9%
0.48%
-11.5%
Q2 2021$40,612,000
-9.6%
461,712
-0.1%
0.55%
-18.0%
Q1 2021$44,920,000
-13.3%
462,0000.0%0.67%
-16.2%
Q4 2020$51,813,000
+21.0%
462,0000.0%0.80%
-5.1%
Q3 2020$42,827,000
+18.8%
462,0000.0%0.84%
+7.0%
Q2 2020$36,036,000
+33.4%
462,0000.0%0.78%
-10.5%
Q1 2020$27,018,000
-27.0%
462,0000.0%0.88%
-16.1%
Q4 2019$37,011,000
+9.0%
462,0000.0%1.04%
-7.0%
Q3 2019$33,943,000
-22.1%
462,0000.0%1.12%
-15.3%
Q2 2019$43,580,000
+17.8%
462,0000.0%1.32%
+4.1%
Q1 2019$36,983,000
+66.5%
462,000
+12.1%
1.27%
+29.5%
Q4 2018$22,211,000
+0.9%
412,000
+46.1%
0.98%
+21.7%
Q3 2018$22,013,000
+131.2%
282,000
+88.0%
0.81%
+104.6%
Q2 2018$9,522,000
-30.8%
150,0000.0%0.40%
-38.7%
Q1 2018$13,755,000
+21.6%
150,0000.0%0.64%
+9.2%
Q4 2017$11,312,000
-31.2%
150,000
-36.4%
0.59%
-36.7%
Q3 2017$16,442,000
+22.4%
236,000
-10.9%
0.93%
+11.5%
Q2 2017$13,428,000
+26.7%
265,0000.0%0.84%
+19.1%
Q1 2017$10,597,000
+42.6%
265,0000.0%0.70%
+45.0%
Q4 2016$7,433,000
-5.6%
265,0000.0%0.48%
+0.6%
Q3 2016$7,871,000
+46.7%
265,0000.0%0.48%
+46.6%
Q2 2016$5,366,000
+20.6%
265,000
+7.5%
0.33%
+31.7%
Q1 2016$4,449,000
-31.5%
246,5000.0%0.25%
-23.4%
Q4 2015$6,493,000
+184.4%
246,500
+130.4%
0.32%
+144.4%
Q3 2015$2,283,000107,0000.13%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 380,012$42,618,0008.86%
DAFNA Capital Management LLC 206,911$23,205,0006.90%
Casdin Capital, LLC 1,550,000$173,833,0005.15%
Eagle Health Investments LP 62,060$6,960,0004.45%
SIB LLC 54,912$6,158,0004.11%
CADIAN CAPITAL MANAGEMENT, LP 1,059,450$118,817,0003.05%
Tri Locum Partners LP 73,906$8,289,0003.01%
Integral Health Asset Management, LLC 85,000$9,533,0002.84%
MAKENA CAPITAL MANAGEMENT LLC 38,924$4,365,0002.42%
Rock Springs Capital Management LP 842,000$94,430,0002.00%
View complete list of BLUEPRINT MEDICINES CORP shareholders